Blog - Page 5225 of 5354

MondayJan 01, 2007 6:13 am

Immune Response (OTCBB: IMNR) Secures Partners for MS Clinical Trials

Immune Response Corporation recently announced on that it has entered into an agreement with Accelsiors CRO & Consultancy Services, a clinical research organization with extensive experience in conducting multiple sclerosis (MS) trials, to oversee the 200-patient Phase II trial of NeuroVax, an investigational T-cell receptor peptide vaccine for the treatment of MS. Immune went on further to announce that in November they will hold a clinical trial meeting in Budapest, Hungary to discuss plans for a multi-center trial. This trial will also be a double-blind placebo control test to further investigate the viability of NeuroVax as a treatment for MS.…

MondayJan 01, 2007 6:13 am

Xechem’s (OTCBB: XKEM) Orphan Drug Status Approved for New Sickle Cell Drug

Recently, the EU approved "Orphan Drug Status" for Xechem International's sickle cell drug dubbed Niprisan, a phytopharmaceutical product that has shown efficacy in the treatment of Sickle Cell Disease. The designation covers all 25 member countries that comprise the European Union. A similar Orphan Drug Status was granted to Xechem by the U.S. Food and Drug Administration. Dr. Ramesh Pandey, Xechem's Chairman & CEO said, "Obtaining Orphan Drug status for our Sickle Cell Disease product in both the European Union and the United States brings to Xechem substantial advantages and incentives which will help facilitate approval of the drug and…

MondayJan 01, 2007 6:09 am

Positron (OTCBB: POSC) May Get a Boost from PET Scanning of Lymphoma Patients

In a recent online edition of Clinical Oncology, PET scanning is introduced for the first time as a standardized method to assess the progression of a patientâ€™s lymphoma treatment. This marks the first time that the standards have been revisited on an international scale. PET imaging, in contrast to traditional CT scanning, can discern the difference between a tumor and scar tissue left behind after a successful surgery. The efficacy of the scanning allows for a definitive diagnosis in both cases of there being no tumor or the presence of one. This will allow for greater speed in treatment for…

MondayJan 01, 2007 6:09 am

Power Air (OTCBB: PWAC) to Commercialize it Zinc Air Fuel Generator

E-mail Power Air (OTCBB: PWAC) recently signed a Memorandum of Understanding (MOU) with Autobotics Inc regarding the recycling of zinc. Under the terms of the agreement, the two companies will work together to manufacture and recycle the spent fuel from the first indoor generator. Power Air then intends to market the zinc fueled generator worldwide as a no emission backup generator for both indoor and outdoor use. The fact that the generator can operate with zero emissions indoor is important to the consumer market. Just within the past few months, vicious winter storms have struck both the Northwest and the…

MondayJan 01, 2007 6:05 am

CompuMed (OTCBB: CMPD) Could Boost Revenue with Grants

The FCC has announced a two-year pilot program that would fund up to 85% of the costs for the design, construction and use of dedicated broadband networks in order to expand the availability and use of tele-health and tele-medicine, particularly in rural areas. Unlike existing rural health subsidy programs, this new program specifically contemplates that major urban health centers would be eligible to participate and receive funding if they include rural health care providers in the network. One of the companies at the forefront of tele-medicine is CompuMed. CompuMed has been a leading pioneer of tele-medicine, establishing one of…

MondayJan 01, 2007 6:04 am

ORAMED PHARMACEUTICL (OTC BB:ORMP.OB)

Understanding diabetes and the role of insulin Diabetes is a common condition in which the amount of glucose (sugar) in the blood is too high because the body is unable to use it properly. This is because the body´s method of converting glucose into energy is not working as it should. Diabetes can lead to serious complications, such as heart disease, strokes, amputations, eye and kidney damage, and premature death. In developing countries, diabetes is the fourth-ranking cause of death. Without question, diabetics have been slaves to syringes long enough. An effective insulin capsule has been long awaited by diabetics…

MondayJan 01, 2007 5:59 am

ZAP (ZAAP) Hopes to Gain Exposure in the Green Market

With Green Fever sweeping the nation, Zap, and electric car manufacturer is looking to capitalize with its new XEBRA XERO truck. This truck, dubbed a ‘city-car’ due to its top speed of 40 mph, qualifies as a zero emission vehicle under EPA guidelines. While not applicable for long distance travel, city fleets could be replaced by this or similar vehicles greatly reducing emissions in smog-prone areas. Uses could range from traffic police use to sanitation to mail courier vehicles. The overall market for efficient vehicles is expanding rapidly due to concern on the U.S. dependence on foreign sources of oil…

MondayJan 01, 2007 5:58 am

Wi-Fi TV (WTVI) Looks to Capitalize on User Content Creation

Over the past year new buzzwords have entered into the realm of internet such as Web 2.0 and User Content Creation. Companies such as YouTube and Myspace have been bought for exorbitant amounts of money only to see revenues become stagnant. The problem with user generated content is that there is no template on how to monetize it. Companies such as Wi-Fi TV have found a way to monetize user generated videos by offering internet TV channels to standalone producers. Tiers of functionality have been developed that allows the user to pay for access to a toolset and even share…

MondayJan 01, 2007 5:55 am

Sierra Gold (SGCP) Prospects Are Good as Goldman Sachs Remains Bullish on Gold

Gold prices over the past week have begun to stabilize and return to their upward trend after a $50 drop following the stock meltdown that started in the Shanghai Index. While gold prices retreated on the employment news released Friday, the price of gold did log an overall 1% gain for the week ending at $652. Goldman Sachs remains bullish on gold, with their expectations being that gold prices will breach the $725 an ounce mark in 2007, with the yearly average hovering in the range of $689. These numbers are predicated on the belief that the dollar will continue…

MondayJan 01, 2007 5:54 am

Intelligentias (ITLI) Stands to Benefit From Proposed ‘Safety Bill’

Intelligentias' wholly-owned subsidiary is currently bolstering its sales marketing force in the likelihood that the ‘Safety Bill’ will pass through Congress and eventually will be signed into law by the President. The overall thrust of the bill is for Internet Service Providers (ISPs) to keep a record of every user to help aid in any future police or terror investigation. A similar law has already been enacted in the European Union and it can be expected to be signed into law in the United States. Essentially the ISPs would be required to engage in indefinite data retention if ordered by…

Site Search

Company Search